Assembly Biosciences, Inc. Profile Avatar - Palmy Investing

Assembly Biosciences, Inc.

Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as co…

Biotechnology
US, South San Francisco [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Assembly Biosciences, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Assembly Biosciences, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Assembly Biosciences, Inc..

End of ASMB's Analysis
CIK: 1426800 CUSIP: 045396108 ISIN: US0453962070 LEI: - UEI: -
Secondary Listings
ASMB has no secondary listings inside our databases.